Thermage snubs new acquisition offer; keeps to Reliant deal
This article was originally published in Clinica
Thermage has rejected an alternative unsolicited acquisition proposal from an unnamed third party, and said it remains committed to its pending $95m merger with fellow skin repair specialist Reliant Technologies. Hayward, California-based Thermage had received the $5.50-per-share offer – payable either in cash or a cash-and-stock mix – from the interested party on August 20. However, the company said the Reliant deal will provide "significantly greater value" to Thermage stockholders. The Reliant/Thermage merger, announced in July (see Clinica No 1315, p 13), is expected to create a leader in the skin tissue repair market. The combined company is said to have generated revenue of $137m for fiscal 2008.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.